Geode Capital Management
IDIX

Geode Capital Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Geode Capital Management’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-642,163
Closed -$15.5M – 3942
2014
Q2 		$15.5M Buy
642,163
+21,451
+3% +$224K 0.01% 992
2014
Q1 		$3.74M Buy
620,712
+105,898
+21% +$739K ﹤0.01% 1967
2013
Q4 		$3.08M Buy
514,814
+67,607
+15% +$313K ﹤0.01% 2043
2013
Q3 		$2.33M Buy
447,207
+31,975
+8% +$140K ﹤0.01% 2077
2013
Q2 		$1.5M Buy
+415,232
New +$1.7M ﹤0.01% 2215

Geode Capital Management's IDIX Position: Q3 2014 in Review

Geode Capital Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 642,163 shares — an estimated $15.5M sold.

Geode Capital Management first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $15.5M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Geode Capital Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Geode Capital Management sold 642,163 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $15.5M.
  • Geode Capital Management first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Geode Capital Management's IDENIX PHARMACEUTICALS INC position peaked at $15.5M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Geode Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.